FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101579911> ?p ?o ?g. }

• W2101579911 abstract "There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are effectiveness, safety and/or budget concerns. Dabigatran, a new oral anticoagulant for the prevention of stroke in patients with non-valvular atrial fibrillation (AF), exemplifies this issue. Whilst new effective treatments are needed, there are issues in the elderly with dabigatran due to variable drug concentrations, no known antidote and dependence on renal elimination. Published studies showed dabigatran to be cost-effective but there are budget concerns given the prevalence of AF. These concerns resulted in extensive activities pre- to post-launch to manage its introduction.To (i) review authority activities across countries, (ii) use the findings to develop new models to better manage the entry of new drugs, and (iii) review the implications based on post-launch activities.(i) Descriptive review and appraisal of activities regarding dabigatran, (ii) development of guidance for key stakeholder groups through an iterative process, (iii) refining guidance following post launch studies.Plethora of activities to manage dabigatran including extensive pre-launch activities, risk sharing arrangements, prescribing restrictions and monitoring of prescribing post launch. Reimbursement has been denied in some countries due to concerns with its budget impact and/or excessive bleeding. Development of a new model and future guidance is proposed to better manage the entry of new drugs, centering on three pillars of pre-, peri-, and post-launch activities. Post-launch activities include increasing use of patient registries to monitor the safety and effectiveness of new drugs in clinical practice.Models for introducing new drugs are essential to optimize their prescribing especially where concerns. Without such models, new drugs may be withdrawn prematurely and/or struggle for funding." @default.
• W2101579911 created "2016-06-24" @default.
• W2101579911 creator A5000053019 @default.
• W2101579911 creator A5001776383 @default.
• W2101579911 creator A5004094193 @default.
• W2101579911 creator A5004142267 @default.
• W2101579911 creator A5005938426 @default.
• W2101579911 creator A5010513682 @default.
• W2101579911 creator A5014828756 @default.
• W2101579911 creator A5017307520 @default.
• W2101579911 creator A5028480298 @default.
• W2101579911 creator A5028684820 @default.
• W2101579911 creator A5030921739 @default.
• W2101579911 creator A5032208400 @default.
• W2101579911 creator A5033660554 @default.
• W2101579911 creator A5034319085 @default.
• W2101579911 creator A5036145940 @default.
• W2101579911 creator A5038508170 @default.
• W2101579911 creator A5042220933 @default.
• W2101579911 creator A5047417686 @default.
• W2101579911 creator A5050383937 @default.
• W2101579911 creator A5051424015 @default.
• W2101579911 creator A5056254777 @default.
• W2101579911 creator A5057686326 @default.
• W2101579911 creator A5058331626 @default.
• W2101579911 creator A5068156590 @default.
• W2101579911 creator A5072474086 @default.
• W2101579911 creator A5074946805 @default.
• W2101579911 creator A5077844105 @default.
• W2101579911 creator A5078194079 @default.
• W2101579911 creator A5079498687 @default.
• W2101579911 creator A5080858676 @default.
• W2101579911 creator A5086342867 @default.
• W2101579911 creator A5090473369 @default.
• W2101579911 creator A5090726068 @default.
• W2101579911 creator A5090787139 @default.
• W2101579911 creator A5091468058 @default.
• W2101579911 creator A5025827617 @default.
• W2101579911 date "2014-06-10" @default.
• W2101579911 modified "2023-10-18" @default.
• W2101579911 title "Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs" @default.
• W2101579911 cites W2034084563 @default.
• W2101579911 doi "https://doi.org/10.3389/fphar.2014.00109" @default.
• W2101579911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4050532" @default.
• W2101579911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24959145" @default.
• W2101579911 hasPublicationYear "2014" @default.
• W2101579911 type Work @default.
• W2101579911 sameAs 2101579911 @default.
• W2101579911 citedByCount "36" @default.
• W2101579911 countsByYear W21015799112014 @default.
• W2101579911 countsByYear W21015799112015 @default.
• W2101579911 countsByYear W21015799112016 @default.
• W2101579911 countsByYear W21015799112017 @default.
• W2101579911 countsByYear W21015799112018 @default.
• W2101579911 countsByYear W21015799112019 @default.
• W2101579911 countsByYear W21015799112020 @default.
• W2101579911 countsByYear W21015799112021 @default.
• W2101579911 countsByYear W21015799112022 @default.
• W2101579911 crossrefType "journal-article" @default.
• W2101579911 hasAuthorship W2101579911A5000053019 @default.
• W2101579911 hasAuthorship W2101579911A5001776383 @default.
• W2101579911 hasAuthorship W2101579911A5004094193 @default.
• W2101579911 hasAuthorship W2101579911A5004142267 @default.
• W2101579911 hasAuthorship W2101579911A5005938426 @default.
• W2101579911 hasAuthorship W2101579911A5010513682 @default.
• W2101579911 hasAuthorship W2101579911A5014828756 @default.
• W2101579911 hasAuthorship W2101579911A5017307520 @default.
• W2101579911 hasAuthorship W2101579911A5025827617 @default.
• W2101579911 hasAuthorship W2101579911A5028480298 @default.
• W2101579911 hasAuthorship W2101579911A5028684820 @default.
• W2101579911 hasAuthorship W2101579911A5030921739 @default.
• W2101579911 hasAuthorship W2101579911A5032208400 @default.
• W2101579911 hasAuthorship W2101579911A5033660554 @default.
• W2101579911 hasAuthorship W2101579911A5034319085 @default.
• W2101579911 hasAuthorship W2101579911A5036145940 @default.
• W2101579911 hasAuthorship W2101579911A5038508170 @default.
• W2101579911 hasAuthorship W2101579911A5042220933 @default.
• W2101579911 hasAuthorship W2101579911A5047417686 @default.
• W2101579911 hasAuthorship W2101579911A5050383937 @default.
• W2101579911 hasAuthorship W2101579911A5051424015 @default.
• W2101579911 hasAuthorship W2101579911A5056254777 @default.
• W2101579911 hasAuthorship W2101579911A5057686326 @default.
• W2101579911 hasAuthorship W2101579911A5058331626 @default.
• W2101579911 hasAuthorship W2101579911A5068156590 @default.
• W2101579911 hasAuthorship W2101579911A5072474086 @default.
• W2101579911 hasAuthorship W2101579911A5074946805 @default.
• W2101579911 hasAuthorship W2101579911A5077844105 @default.
• W2101579911 hasAuthorship W2101579911A5078194079 @default.
• W2101579911 hasAuthorship W2101579911A5079498687 @default.
• W2101579911 hasAuthorship W2101579911A5080858676 @default.
• W2101579911 hasAuthorship W2101579911A5086342867 @default.
• W2101579911 hasAuthorship W2101579911A5090473369 @default.
• W2101579911 hasAuthorship W2101579911A5090726068 @default.
• W2101579911 hasAuthorship W2101579911A5090787139 @default.
• W2101579911 hasAuthorship W2101579911A5091468058 @default.
• W2101579911 hasBestOaLocation W21015799111 @default.
• W2101579911 hasConcept C144133560 @default.
• W2101579911 hasConcept C160735492 @default.
• W2101579911 hasConcept C162324750 @default.
• W2101579911 hasConcept C164705383 @default.

• next